QELBREE 150 mg/1 (Viloxazine Hydrochloride CAPSULE, EXTENDED RELEASE) 150 mg/1

QELBREE 150 mg/1 is an extended-release capsule containing viloxazine hydrochloride, used for managing certain conditions. This medication is designed for oral administration and is manufactured by Supernus Pharmaceuticals, Inc.

Strength

150 mg/1

Pack Size

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-132-30)

Manufacturer / TM Owner

Supernus Pharmaceuticals, Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

QELBREE 150 mg/1 is primarily used for managing symptoms associated with specific mental health conditions. Viloxazine hydrochloride, the active ingredient, is often prescribed to help improve focus and reduce impulsivity. This medication is designed to provide extended relief, making it suitable for daily use. What is QELBREE used for? It is commonly used to manage symptoms that require long-term treatment.

Side Effects

Common effects of QELBREE 150 mg/1 may include changes in appetite, sleep disturbances, and mild gastrointestinal discomfort. Some users may experience dizziness or headaches, especially when starting the medication. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Precautions & Warnings

QELBREE 150 mg/1 should be stored at room temperature and kept out of reach of children. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Do not crush or chew the extended-release capsules, as this can affect the medication's release mechanism.

Avoid Interactions

QELBREE 150 mg/1 may interact with certain medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other central nervous system depressants should be used with caution while taking this medication.

Frequently Asked Questions

QELBREE 150 mg/1 is used to manage symptoms associated with certain mental health conditions, such as improving focus and reducing impulsivity.

QELBREE 150 mg/1 should be taken orally, preferably with food, and the capsules should not be crushed or chewed.

Common side effects may include changes in appetite, sleep disturbances, mild gastrointestinal discomfort, dizziness, and headaches.

It is advisable to use alcohol with caution while taking QELBREE 150 mg/1, as it may interact with the medication.

QELBREE 150 mg/1 should be stored at room temperature and kept out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.